1Konoplyannikov AG. Biological effects of γ-neutron radiation 252cf or fession neutron from the BR-10 reactor on tumor and normal cells and tissues[A]. In·Jacel GW. Californium-252 isotope for 21stcentury radiotherap[M]. Defroit: Kluwer Academic Publishe
2Burneckis A, Atkoius V, Sinkevicius Z. Preperative radiotherapy in the treatment of rectal carcinoma[A]. In·Jacel GW. Californium-252 isotope for 21stcentury radiotherap[M]. Defroit: Kluwer Academic Publishers. 1996.199-202.
3Maruyama Y ,Mesina J, Yudelev M, et al. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulkygyn carcinoma for future[J]. Strahlenther Onkol, 1994,170(5):253-263.
4Patchell RA,Yaes RJ, Beach L, et al. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas[J]. Br J Radiol, 1997,70(839):1162-1168.
5Masunaga S, Ono K, Akuta K, et al. The response of quiescent cell populations in murine solid tumors to irradiation with fast neutrons[J]. Acta Oncol ,1994,33(7):813-817.
6Vtyruin BM, Medvedev VS,Ivanov VN, et al. Perioperative neutron brachytherapy with californium-252[J]. Int J Oncol Biol Phys,1992,23(4):873-879.
8Atkoius V, Burneckis A, Atkoien V. Clinical radiobiology of HDR Cf-252 brachytherapy for rectal cancer[J]. Radiother Oncol, 1995,37(1):13-17.
9Patchell RA, Maruyama Y,Tibbs PA, et al. Neutron interstitial brachytherapy for malignant gliomas: a pilot study[J]. J-Neurosurg , 1988,68(1):67-72.
10Jacek G, Wierzbicki, Mark J, et al. Physics and dosimetry of clinical 252cf sources[A]. In·Jacel GW. Californium-252 isotope for 21st century radiotherapy[M]. Defroit: Kluwer Academic Publishers.1998.25-53.
